Aelis Farma SAS - Company Review
Aelis Farma SAS - Company ReviewSummary
Aelis Farma SAS (Aelis Farma) is a healthcare company that conducts research and development of signaling specific drugs. The company develops cannabinoid receptor type 1 signaling specific inhibitors. Its signaling specific therapeutics targets the G-protein-coupled receptors. Aelis Farma’s CB1 receptors find application in treating various diseases such as psychosis, mental retardation, metabolic disorders and skin diseases, among others. The company’s product modulates the signaling pathway related with the disease and offers pharmaceutical compounds with required therapeutic efficacy and fewer side effects. It operates through research centers and universities for developing new signaling biased drugs. The company serves healthcare sector. Aelis Farma is headquartered in Bordeaux, France.
This comprehensive company report of Aelis Farma SAS provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.